Product Information

POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0838 per EA under NDC 16571084301. Its NADAC has been published 61 times since Jun 25, 2025.

FDA first approved this application on Dec 19, 2023. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 10 MEQ TABLET

potassium chloride
$0.0838per EA

Strength

750 mg/1

NDC

16571084301

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA217412

FDA Approved

12/19/2023

TE Code

AB2

On Market Since

2/13/2025

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 61 times since Jun 25, 2025, and over the history we have for it it has declined 12.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0838 per EA
All-time high$0.0959 (Jul 16, 2025)
All-time low$0.0838 (Aug 19, 2026)
52-week high$0.0943
52-week low$0.0838
Median price$0.0886
Average price$0.0894
Largest weekly change+6.0% (Dec 17, 2025)
Weeks tracked61
Tracking sinceJun 25, 2025

Price History

1W

-1.4%

1M

-1.4%

3M

-5.1%

6M

-7.4%

1Y

-6.0%

3Y

N/A

5Y

N/A

All

-12.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0838 per EA (NDC 16571084301), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has declined 12.7%. It has been tracked across 61 weekly CMS publications since Jun 25, 2025.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?

Since Jun 25, 2025, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0838 (Aug 19, 2026) to a high of $0.0959 (Jul 16, 2025), with a median of $0.0886 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 10 MEQ TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CL ER 10 MEQ TABLET?

POTASSIUM CL ER 10 MEQ TABLET (NDC 16571084301) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.